1 / 58

Canada Pharmaceutical Excipient Market Analysis

This report presents a strategic analysis of the Canada Pharmaceutical Excipient Market and a forecast for its development in the medium and long term. It provides a comprehensive overview of the market value, dynamics, segmentation, main players, growth and demand drivers, challenges & future outlook, etc. This is one of the most comprehensive reports about the Canada Pharmaceutical Excipient Market, and offers unmatched value, accuracy, and expert insights.

Insights10
Download Presentation

Canada Pharmaceutical Excipient Market Analysis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Sample Report Canada Pharmaceutical Excipient Market Analysis May 2024

  2. This report presents a strategic analysis of the Canada Pharmaceutical Excipient Market and a forecast for its development in the medium and long term. It provides a comprehensive overview of the market value, dynamics, segmentation, main players, growth and demand drivers, challenges & future outlook, etc. This is one of the most comprehensive reports about the Canada Pharmaceutical Excipient Market, and offers unmatched value, accuracy, and expert insights.

  3. Report Scope Report Attribute Details Number of Pages 70-80 Base Year for Estimation 2023 Forecast Period 2024-2030 Market Overview, Size & Forecasting, Market Segmentation, Growth Factors and Trends, Competitive Landscape, Key Company Profiles, Government Policies, Regulatory Landscape, Reimbursement Scenario Report Coverage Quantitative Units Revenue in USD Million/Billion (Mn/Bn) Currency Conversion 1 Canadian Dollar = 0.73 USD Research Approach Secondary Research (90%), Primary Research (10%) 3 A Sample Report on Canada Pharmaceutical Excipient Market Analysis I Confidential

  4. Table of Content CONTENT PG. NO. 06 – 14 1. Market Overview 1.1 Pharmaceutical Excipient Market Overview 1.2 Pharmaceutical Excipient Market Overview: Global 1.3 Economic Overview: Canada 1.4 Pharmaceutical Excipient Market Overview: Canada 1.5 Healthcare Overview: Canada 1.6 Budget of Canada Government for Public Insurance 1.7 Top Developments in Canada 15 – 16 2. Pharmaceutical Excipients Categories 2.1 Types of Pharmaceutical Excipients 17 – 23 3. Market Size and Forecasting 3.1 Canada Pharmaceutical Excipient Market Size and Forecasts 3.2 Snapshot of Canada Pharmaceutical Excipient Market Segmentation 4 A Sample Report on Canada Pharmaceutical Excipient Market Analysis I Confidential

  5. Table of Content CONTENT PG. NO. 3.2.1 Market Segmentation: By Product Type 3.2.2 Market Segmentation: By Formulation Type 3.2.3 Market Segmentation: By Geographic 23 – 28 4. Market Dynamics 4.1 Market Growth Drivers 4.2 Market Restraints 29 – 32 5. Competitive Landscape 5.1 Key Players in Canada Pharmaceutical Excipient Market 33 – 37 6. Reimbursement Scenario 6.1 Reimbursement Regulation in Canada 6.2 Reimbursement Process 5 A Sample Report on Canada Pharmaceutical Excipient Market Analysis I Confidential

  6. Canada Pharmaceutical Excipient Market Analysis 1. Market Overview

  7. 1.1 Pharmaceutical Excipient Market Overview Pharmaceutical excipients are inactive substances formulated alongside the active ingredient of a medication ▪ They serve various roles in the drug manufacturing process, including aiding in the drug's delivery, stability, and overall performance ▪ Although they do not have therapeutic effects, excipients are crucial for ensuring that the active pharmaceutical ingredient (API) is effectively delivered and absorbed in the body ▪ Usage of Pharmaceutical Excipients ▪ Excipients like lactose and cellulose are used to adjust the volume of active ingredients, ensuring consistent dosing​ Preservatives such as parabens and antioxidants like ascorbic acid are added to formulations to prolong shelf life and prevent degradation Disintegrants such as starch and crospovidone ensure that tablets break down properly after ingestion, while coating agents like HPMC protect the drug from environmental factors and control the release rate Flavoring agents and sweeteners like aspartame and saccharin improve the taste of oral medications, and colorants such as titanium dioxide enhance the appearance​ Binders such as polyvinylpyrrolidone and methylcellulose hold ingredients together in a cohesive mix, and lubricants like magnesium stearate prevent sticking during manufacturing ▪ ▪ ▪ ▪

  8. 1.2 Pharmaceutical Excipient Market Overview: Global (1/2) 19.8 Mn Deaths globally due to cardiovascular diseases in 2022 Global Pharmaceutical Market Size (In Bn) 537 Mn Number of diabetics worldwide in 2021 1.4 Bn Population of people aged 60 years and older in 2030 38.6 Nurses per 10,000 people across the world in 2023 2013 2014 2015 2016 2017 2018 2019 2020 Illustrative Illustrative 2021 2022 8 A Sample Report on Canada Pharmaceutical Excipient Market Analysis I Confidential Sources:

  9. 1.2 Pharmaceutical Excipient Market Overview: Global (2/2) Canada Market ~$xx Bn Market Illustrative Illustrative 9 A Sample Report on Canada Pharmaceutical Excipient Market Analysis I Confidential

  10. 1.3 Economic Overview: Canada Population of Canada, (2023-2030) GDP of Canada, (2023-2030) 2023 2024F 2025F 2026F 2027F 2028F 2029F 2023F 2023 2024F 2025F 2026F 2027F 2028F 2029F 2023F Population Split (2023) Canada is an ageing country, as its median age is 40.6 years which is higher than the global median age ▪ By Gender By Age Group Country’s population is equivalent to 0.48% of the total world population Life expectancy of females is 84.9 years and for males it is 81.1 years Currently 81.4% of the population is urban in Canada Top 3 largest cities in Canada are Toronto, Montreal and Calgary ▪ 0-14 ▪ 15-64 Male Female ▪ 65+ ▪ Illustrative Illustrative 10 A Sample Report on Canada Pharmaceutical Excipient Market Analysis I Confidential

  11. 1.4 Pharmaceutical Excipient Market Overview: Canada 197 out of 100,000 Canadians died from major cardiovascular diseases in 2022 Canada Pharmaceutical Market Size (In Bn) 7.8% Canadians reported that they had been diagnosed with Diabetes in 2022 19.3% Canadians of people aged 60 years and older in 2022 19,716 Canadians died from covid 19 in 2022 2013 2014 2015 2016 2017 2018 2019 2020 Illustrative Illustrative 2021 2022 11 A Sample Report on Canada Pharmaceutical Excipient Market Analysis I Confidential Sources:

  12. 1.5 Healthcare Overview: Canada Public Healthcare Private Healthcare Universal Coverage: All citizens and permanent residents are covered for medically necessary services Supplementary Insurance: Many Canadians purchase private health insurance to cover services not included in the public system, such as prescription medications, dental care, and physiotherapy ▪ ▪ Funding: Primarily tax-funded, with federal transfers supporting provincial and territorial healthcare budgets ▪ Private Clinics and Services: Some private clinics offer services such as elective surgeries, diagnostics, and faster access to certain specialists, typically funded out-of-pocket or through private insurance ▪ Accessibility: Designed to provide equitable access to healthcare services regardless of an individual's ability to pay ▪ Services Covered: Includes hospital stays, physician services, and surgeries, but generally excludes prescription drugs, dental care, and vision care outside of hospital settings ▪ Employer-Sponsored Plans: A significant portion of Canadians receive supplementary health benefits through employer- sponsored insurance plans, which cover a range of additional health services ▪ Provincial/Territorial Management: Each province and territory administers its own healthcare plan, adhering to national principles set out in the Canada Health Act ▪ Regulation: Private healthcare providers and insurers are regulated to ensure they complement rather than duplicate the public system, maintaining the integrity of universal coverage principle ▪ 12 A Sample Report on Canada Pharmaceutical Excipient Market Analysis I Confidential

  13. 1.6 Budget of Canada Government for Public Insurance Proposed Budget By Category 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2022-31 Outlays $769 $709 $766 $841 $840 $947 $1,014 $1,085 $1,227 $1,178 $1,325 $1,412 $10,633 In Billions Of Dollars Medicare 3.7% 3.2% 3.3% 3.4% 3.3% 3.6% 3.7% 3.8% 4.1% 3.8% 4.1% 4.2% 3.7% As % Of GDP National Health Expenditures (NHE) grew 2.7% to $4.3 trillion in 2021, or $12,914 per person, and accounted for 18.3% of Gross Domestic Product (GDP) ▪ Public Insurance spending grew 8.4% to $900.8 billion in 2021, or 21% of total NHE ▪ Private health insurance spending grew 5.8% to $1,211.4 billion in 2021, or 28% of total NHE ▪ Out of pocket spending grew 10.4% to $433.2 billion in 2021, or 10% of total NHE ▪ Other Third Party Payers and Programs and Public Health Activity spending declined 20.7% in 2021 to $596.6 billion, or 14% of total NHE ▪ Hospital expenditures grew 4.4% to $1,323.9 billion in 2021, slower than the 6.2% growth in 2020 ▪ Physician and clinical services expenditures grew 5.6% to $864.6 billion in 2021, slower growth than the 6.6% in 2020 ▪ Prescription drug spending increased 7.8% to $378.0 billion in 2021, faster than the 3.7% growth in 2020 ▪ Largest shares of total health spending were sponsored by the federal government (34%) and the households (27%). The private business share of health spending accounted for 17% of total health care spending, state and local governments accounted for 15%, and other private revenues accounted for 7% ▪ Illustrative Illustrative 13 A Sample Report on Canada Pharmaceutical Excipient Market Analysis I Confidential

  14. 1.7 Top Developments in Canada Latest Deals in Canada Company Name Type Year Key Pointers Apotex, a major Canadian pharmaceutical company, announced its acquisition of Searchlight Pharma, which specializes in women’s health, urology, endocrinology, and hospital specialty drugs​ Acquisition further accelerates Apotex's growth within the specialty branded pharmaceutical market, adding a diverse portfolio of over 60 products and a full-service branded pharmaceutical platform, as well as established business development networks in Canada and internationally ▪ ▪ Acquisition April, 2024 Appili Therapeutics Inc., a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures announced that it has entered into a definitive arrangement agreement with Appili Therapeutics, a Canadian company focused on infectious diseases and biodefense Acquisition includes FDA-approved products and a vaccine candidate funded by the US Department of Defense ▪ Acquisition April, 2024 ▪ Illustrative Illustrative 14 A Sample Report on Canada Pharmaceutical Excipient Market Analysis I Confidential

  15. Canada Pharmaceutical Excipient Market Analysis 2. Pharmaceutical Excipients Categories

  16. 2.1 Types of Pharmaceutical Excipients By Chemical Nature By Functionality Provide bulk to the formulation (e.g., lactose, microcrystalline cellulose) Fillers and Diluents Used as binders, film-forming agents, and controlled- release matrices (e.g., cellulose derivatives, polyvinyl alcohol) Polymers Help in granulation and cohesion of tablets (e.g., starch, HPMC) Binders Promote tablet breakdown in the digestive system (e.g., sodium starch glycolate, croscarmellose sodium) Disintegrants Solvents and plasticizers (e.g., ethanol, propylene glycol) Alcohols Prevent tablet components from sticking to equipment (e.g., magnesium stearate, talc) Lubricants Protect the drug and control its release (e.g., gelatin, ethylcellulose) Coating Agents Fillers and sweeteners (e.g., lactose, sucrose) Sugars Inhibit microbial growth (e.g., parabens, benzalkonium chloride) Preservatives Improve taste and patient compliance (e.g., sucrose, aspartame) Flavoring Agents and Sweeteners Fillers and disintegrants (e.g., calcium phosphate, silicon dioxide) Minerals Enhance the visual appeal and aid in identification (e.g., titanium dioxide, iron oxides) Illustrative Illustrative Colorants 16 A Sample Report on Canada Pharmaceutical Excipient Market Analysis I Confidential

  17. Canada Pharmaceutical Excipient Market Analysis 3. Market Size and Forecasting

  18. 3.1 Canada Pharmaceutical Excipient Market Size and Forecasts Canada Pharmaceutical Excipient Market Forecast, 2023-2030 2023 2024F 2025F 2026F 2027F 2028F 2029F 2030F 2023 2024 2025 2026 2027 2028 2029 2030 Major Markets Patient ($Mn) 2.74 2.82 2.90 2.94 2.98 3.02 3.07 3.12 Canada Patient Size ($Bn) 0.51 0.61 0.68 0.69 0.70 0.71 0.72 0.73 % of Patients 18.75% 21.70% 23.56% 23.45% 23.42% 23.39% 23.34% 23.45% Global Market Size ($Bn) 3,620 3,780 3,950 4,128 4,314 4,508 4,711 4,937 Canada Market Size ($Bn) 61 74 84 87 91 95 99 106 Illustrative Illustrative 18 A Sample Report on Canada Pharmaceutical Excipient Market Analysis I Confidential

  19. 3.2 Snapshot of Canada Pharmaceutical Excipient Market Segmentation Product Type Formulation Type Geographic Organic Chemicals Oral Formulations Ontario Inorganic Chemicals Topical Formulations Quebec Parenteral Formulations British Columbia Other Formulations Alberta Atlantic Canada In this section you will get an understanding of the segmentations which will cover the Canada Pharmaceutical Excipient Market ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Illustrative Illustrative 19 A Sample Report on Canada Pharmaceutical Excipient Market Analysis I Confidential

  20. 3.2.1 Market Segmentation: By Product Type Canada Pharmaceutical Excipient Market Share, By Product Type (2023) Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report In order to obtain access to all of the information that you are seeking, you will need to purchase the final report Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ ▪ Inorganic Chemicals ▪ Organic Chemicals Illustrative Illustrative 20 A Sample Report on Canada Pharmaceutical Excipient Market Analysis I Confidential

  21. 3.2.2 Market Segmentation: By Formulation Type Canada Pharmaceutical Excipient Market Share, By Formulation Type (2023) Other Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report In order to obtain access to all of the information that you are seeking, you will need to purchase the final report Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest Formulations ▪ Oral Formulations ▪ Parenteral Formulations ▪ Topical Formulations Illustrative Illustrative 21 A Sample Report on Canada Pharmaceutical Excipient Market Analysis I Confidential

  22. 3.2.3 Market Segmentation: By Geographic Canada Pharmaceutical Excipient Market Share, By Geographic (2023) Atlantic Canada Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report In order to obtain access to all of the information that you are seeking, you will need to purchase the final report Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Ontario ▪ Alberta ▪ British Columbia Quebec Illustrative Illustrative 22 A Sample Report on Canada Pharmaceutical Excipient Market Analysis I Confidential

  23. Canada Pharmaceutical Excipient Market Analysis 4. Market Dynamics

  24. 4. Snapshot Of Market Growth Drivers And Restraints 4.1.1 Increasing prevalence of chronic diseases such as diabetes, cancer, and cardiovascular diseases 4.1.2 4.1.3 Technological advancements in drug delivery systems Stringent regulatory standards and quality control measures in Canada 4.2.1 4.2.2 Competition from Low-Cost Regions 4.2.3 Declining Investment in Excipients Rising cost of raw materials and manufacturing Illustrative Illustrative 24 A Sample Report on Canada Pharmaceutical Excipient Market Analysis I Confidential

  25. 4.1 Market Growth Drivers 4.1.1 Increasing prevalence of chronic diseases such as diabetes, cancer, and cardiovascular diseases in Canada % of Chronic Diseases in Canada Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Illustrative Illustrative 25 A Sample Report on Canada Pharmaceutical Excipient Market Analysis I Confidential

  26. 4.1 Market Growth Drivers 4.1.2 Technological advancements in drug delivery systems, including the development of new formulations like controlled-release and targeted delivery mechanisms Use of Nanotechnology in Canada Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 2010 2022 2030 Illustrative Illustrative 26 A Sample Report on Canada Pharmaceutical Excipient Market Analysis I Confidential

  27. 4.1 Market Growth Drivers 4.1.3 Stringent regulatory standards and quality control measures in Canada ensure the high quality of pharmaceutical excipients Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ Regulatory Bodies Responsibility In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Illustrative Illustrative 27 A Sample Report on Canada Pharmaceutical Excipient Market Analysis I Confidential

  28. 4.2 Market Restraints 4.2.1 Rising cost of raw materials and manufacturing 4.2.3 Declining Investment in Excipients 4.2.2 Competition from Low- Cost Regions Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report In order to obtain access to all of the information that you are seeking, you will need to purchase the final report Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report In order to obtain access to all of the information that you are seeking, you will need to purchase the final report Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ ▪ ▪ ▪ ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Our analysis will thoroughly investigate the key restraints that may significantly impact business operations and growth. Illustrative Illustrative 28 A Sample Report on Canada Pharmaceutical Excipient Market Analysis I Confidential

  29. Canada Pharmaceutical Excipient Market Analysis 5. Competitive Landscape

  30. 5.1 Key Players in Canada Pharmaceutical Excipient Market Here is the list of top 10 companies which will cover in the final report ▪ 1 6 Each company will have slides for ▪ DFE Pharma SPI Pharma Overview Key details Offerings Name of products Recent activities/ Press Coverage Distribution and Vendor Partners Mergers, Acquisitions and Collaboration Financials (if available) If there are specific companies that you would like to be included in the report, please let us know via email In order to obtain access to all of the information that you are seeking, you will need to purchase the final report Illustrative Illustrative o o o o 2 7 Colorcon BASF o o o 3 8 Croda International Ashland o ▪ 4 9 Kerry Group FMC Corporation ▪ 10 5 Merck KGaA Roquette 30 A Sample Report on Canada Pharmaceutical Excipient Market Analysis I Confidential

  31. 5.1.1 DFE Pharma (Continued) Offerings ▪ DFE Pharma is a prominent company in the pharmaceutical excipients market, renowned for its comprehensive portfolio of high-quality excipients that are essential for the formulation and manufacturing of pharmaceutical products ▪ DFE Pharma offers a variety of excipients under the Lactohale series, specifically designed for dry powder inhalation (DPI) formulations ▪ In addition to the Lactohale series, DFE Pharma provides other excipients tailored for inhalation products Founded In: 2005 ➢ Pharmatose® HQ: Goch, Germany ➢ SuperTab® Type: Private ➢ Lactopress® Revenue: $19.44 Bn (Global) ➢ BioHale® Website: dfepharma.com ➢ Primojel® Recent Activity / Press Coverage ▪ August 25, 2023 — DFE Pharma has recently become a partner in the UK's Medicines Manufacturing Innovation Centre, which aims to advance pharmaceutical manufacturing processes. This collaboration will help accelerate Phase 1 of Grand Challenge 1, focusing on developing innovative manufacturing solutions and reducing associated costs and risks ▪ March 03, 2023 — DFE Pharma has played a crucial role in the pharmaceutical industry by providing high-quality excipients used in COVID-19 vaccines and treatments. Their excipients are essential in ensuring the stability and effectiveness of these medicines​ ▪ February 15, 2023 — Company is actively involved in developing new technologies, such as lactose powder bed three-dimensional printing. This innovation is part of their ongoing efforts to advance excipient technology and improve pharmaceutical manufacturing processes 31 A Sample Report on Canada Pharmaceutical Excipient Market Analysis I Confidential

  32. 5.1.1 DFE Pharma (Continued) Latest Deals in Canada Company Name Type Year Key Pointers Merger March, 2023 Acquisition 2021 Illustrative Illustrative 32 A Sample Report on Canada Pharmaceutical Excipient Market Analysis I Confidential

  33. Canada Pharmaceutical Excipient Market Analysis 6. Reimbursement Scenario

  34. 6.1 Reimbursement Regulation in Canada (Continued) In Canada, pharmaceutical reimbursement regulation involves a complex interplay between federal and provincial systems. Here’s an overview of how it works: Public Drug Plans: Each province and territory administers its own public drug plans, covering specific populations such as seniors, low- income individuals, and those with certain chronic conditions. These plans determine which drugs are covered based on formularies, which list approved medications and the conditions under which they are reimbursed​ ▪ Health Technology Assessments (HTA): To decide which drugs to include in public formularies, provinces often rely on HTAs. These assessments evaluate the clinical and cost-effectiveness of new medications. Agencies like the Canadian Agency for Drugs and Technologies in Health (CADTH) play a key role in this process by providing recommendations to provincial health ministries ▪ Private Drug Plans: significant portion of Canadians are covered by private insurance plans, either provided by employers or purchased individually. These plans vary widely in terms of coverage and formularies. Private insurers often follow the public HTA recommendations but may have their own criteria and negotiations with pharmaceutical companies​ ▪ Pan-Canadian Pharmaceutical Alliance (pCPA): pCPA negotiates prices on behalf of public drug plans across Canada to achieve better pricing and access to drugs. This collaborative approach helps control costs and streamline the process of bringing new drugs to market in Canada​ ▪ Emerging National Pharmacare: There is ongoing debate and development towards a national pharmacare program, which aims to provide more consistent and comprehensive drug coverage across the country. Recent legislative efforts, like Bill C-64, seek to establish a framework for universal pharmacare, though the specifics are still under discussion ▪ Illustrative Illustrative 34 A Sample Report on Canada Pharmaceutical Excipient Market Analysis I Confidential

  35. 6.1 Reimbursement Regulation in Canada (Continued) Coverage Penetration (% Total Population) Source of Funding Spend on Healthcare (%of Current Health Expenditure) 100% 100% 100% 100% 100% 44.0% Government Expenditure xx 46.0% xx 47.7% xx xx xx 51.0% 51.8% Public Healthcare Coverage Private Health Insurance Out of Pocket 38.9% 37.1% 35.6% 31.5% 32.5% Private Coverage Other NA NA 2019 2020 2021 2022 2023 2017 2018 2019 2020 2021 2022 2023  Public healthcare coverage is provided by the government and includes programs like Medicare and Medicaid  Medicare is a federal program that provides healthcare coverage to individuals who are 65 years of age or older, as well as certain younger people with disabilities 6.3% 4.08% 5.1% 3.8% 2.2% 2.4% 3.6% GDP Growth (yoy) 14.7% 11.3% 15.5% 7.5% 4.2% NA NA HC Spend Growth (yoy) Reimbursement Market Trends ▪ Shift towards value-based care has been a significant trend in Canada healthcare system, with payers and providers increasingly focused on improving patient outcomes and reducing costs ▪ This has led to the development of alternative payment models such as accountable care organizations (ACOs) and bundled payment arrangements, which incentivize providers to deliver high-quality, cost-effective care Illustrative Illustrative 35 A Sample Report on Canada Pharmaceutical Excipient Market Analysis I Confidential

  36. 6.2 Reimbursement Process The reimbursement process in Canada healthcare system can be complex and can vary depending on the type of healthcare service, the healthcare provider, and the insurance coverage. Here are the general steps involved in the reimbursement process: Service or Treatment Provided: The healthcare provider performs a service or treatment for the patient ▪ Billing: The healthcare provider submits a claim to the insurance company or other payer, requesting reimbursement for the service provided ▪ Adjudication: The insurance company or other payer reviews the claim to determine whether it meets the criteria for reimbursement. This can involve verifying the patient's eligibility, reviewing the treatment provided, and checking for any potential errors or fraud ▪ Payment: If the claim is approved, the insurance company or other payer reimburses the healthcare provider for the service provided, based on the negotiated payment rates or fee schedule ▪ Patient Responsibility: Depending on the patient's insurance coverage, they may be responsible for paying a portion of the cost of the service, such as deductibles, co-payments, or co-insurance In order to obtain access to all of the information that you are seeking, you will need to purchase the final report Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Illustrative Illustrative 36 A Sample Report on Canada Pharmaceutical Excipient Market Analysis I Confidential

  37. 6.2 Reimbursement Process (Continued) The reimbursement process in Canada healthcare system can be complex and can vary depending on the type of healthcare service, the healthcare provider, and the insurance coverage. Here are the general steps involved in the reimbursement process: MoH Service or Treatment Provided: The healthcare provider performs a service or treatment for the patient ▪ Market Authorization Billing: The healthcare provider submits a claim to the insurance company or other payer, requesting reimbursement for the service provided ▪ Private Payers Public Payers Adjudication: The insurance company or other payer reviews the claim to determine whether it meets the criteria for reimbursement. This can involve verifying the patient's eligibility, reviewing the treatment provided, and checking for any potential errors or fraud ▪ Health Technology Assessment Payment: If the claim is approved, the insurance company or other payer reimburses the healthcare provider for the service provided, based on the negotiated payment rates or fee schedule ▪ 1 2 3 Coding Coverage Payment Coding depends on availability code while coverage and payment process decisions are made through an HTA. Illustrative Illustrative 37 A Sample Report on Canada Pharmaceutical Excipient Market Analysis I Confidential

  38. A division of

  39. Life-sciences Market Research Reports you can trust We maintain an extensive database comprising over 30,000 syndicated market research reports within the pharmaceuticals and healthcare sector, offering a global, regional, and country-level perspective. Our services also include the provision of customized research reports, meticulously tailored to align with your specific requirements. www.insights10.com

  40. Pharma (Diseases & Drugs) Digital Health Market Research Reports across various categories in healthcare OTC & Medical Devices Nutraceuticals At Insights10, our extensive report library spans a diverse range of categories within the field of life sciences. Clinical Trials Healthcare Services Rare Diseases www.insights10.com

  41. Global Coverage Europe • UK • Germany • France • Italy • Canada • Russia • Netherlands • Sweden • Romania • Switzerland • Poland • Austria • Ireland • Norway • Denmark • Belgium • Portugal • Ukraine • Bulgaria • Finland APAC • India • China • South Korea • Japan • Australia • Indonesia • Hong Kong • New Zealand • Philippines • Singapore • Malaysia • Thailand • Vietnam North America • US • Canada Africa • Egypt • Kenya • South Africa • Algeria • Nigeria • Libya • Tanzania • Morocco Middle East • UAE • Saudi Arabia • Turkey • Lebanon • Kuwait • Qatar Latin America • Brazil • Argentina • Mexico • Ecuador • Venezuela • Senegal Click on the country to see the reports available

  42. What do our reports cover? Market Overview Competitive Landscape 1 6 Growth Drivers & Growth Restraints 2 7 Policy & Regulatory Landscape Epidemiology & Disease type 3 8 Reimbursement Scenario Market Size & Forecast Recent Developments 4 9 Market Segmentation Factors Driving Future Growth 5 10

  43. Our Research Process 01 02 03 04 05 06 Define precise research questions Gather data through secondary research Validate data through primary research interviews Forecast market size and segment analysis Extract key insights from the research findings Compile & present a comprehensive analytical report

  44. Data Triangulation & Data Validation Top Down Approach Find final Examine the total healthcare expenditure in the targeted disease or service domain. market size Assess the proportion of spending allocated to the specific product or treatment category. Predict future market growth or decline based on key market trends & dynamics Predict future market growth or decline based on key market trends & dynamics Analyze product or treatment pricing and reimbursement strategies Find final market size Evaluate consumer or patient demographics and numbers Bottom Up Approach

  45. Report Scope Time Frame Report Attribute Details Quantitative Units Revenue in USD Million/Billion (Mn/Bn) Our pricing and purchase options are adaptable to suit the specific scope of work. Pricing and Purchase Base Year for estimation 2023 Typically, the delivery of the final report falls within a timeframe of 5 to 7 business days, but the exact duration may vary depending on the project's scope. Delivery Timeline Forecast Period 2024- 2030 We are pleased to offer you the option of customizing the report to align with your specific research requirements at no extra charge, provided it falls within the defined scope of the project. Customization

  46. Statistical Databases Press Releases Annual Reports Access to credible data sources for secondary research We have access to a multitude of highly dependable data sources, supported by years of experience that guide us in discerning which sources are most reliable and current for the specific information needed. White- papers Trade Publications Published Research Reports Online Databases www.insights10.com

  47. Our reports present data, which is The report is prepared using a proven methodology and insightful research Reliable The report is prepared by a team of highly qualified & experienced research analysts & vetted by our local associates Expert Verified The report allows you to confidently make smarter business and strategic decisions based on realistic findings Realistic Covers everything you would need to know about the market including market size, competitive analysis & much more Comprehensive You do not have to be a market expert to understand what really is happening on the market and how it works Easy to read

  48. Our Services Customized Market Research Reports Primary Research & Interviews Syndicated Market Research Reports Full-Time Engagement Conference Coverage Database Service & KOL Mapping Yearly Access (Subscription) Regulatory Compliance Competitive Intelligence

  49. CEO Speaks “The business decision-making process is no longer as straightforward as it used to be. It requires insights generated at the right time, based on reliable data interpreted in a nuanced manner for each market. We at Insights10 are building the future of market research and are committed to providing our clients with the right intelligence and insights to make business decisions quickly and efficiently. Insights10 is a unique platform that combines deep domain expertise, nuanced data at a country and functional area level, and years of experience working with some of the best organizations in the world, generating insights that provides substantial competitive advantage.” Dr. Purav Gandhi, Founder & CEO Click to watch Our Introductory Video here

  50. Leadership Team Dr. Purav Gandhi Founder & CEO Anish Swaminathan Director Mukesh Nayak Head – Marketing & Research Ritu Baliya Engagement Manager Purav is a physician and an entrepreneur with 12+ years of experience in Healthcare & Life Sciences industry spanning across strategy, market access, health informatics and RWE, digital health, analytics and data science. Purav studied medicine from Gujarat University and also completed his MBA from IIM-Kozhikode. Purav started his career with Deloitte working on strategy consulting engagements and also co- founded ConvergeHealth by Deloitte. Anish has 15+ years of experience in management consulting in the Life Sciences sector, and has worked with diverse multinational firms in the US, India, Middle East and APAC regions. His primary area of interest is Customer and Market Strategy, Market Access, and Digital Health with special focus on emerging markets like Africa, Middle East and APAC. Mukesh is an engineering graduate with an MBA in Marketing. He is a seasoned healthcare market research & marketing professional with a progressive experience of over 20 years in Life Sciences, Healthcare services, Pharma and Medical Device sectors. With an in-depth understanding of primary research, he has conducted hundreds of interviews of various stakeholders in pharma & healthcare & completed several research projects across life sciences industry. Ritu has over 6 years of experience in strategy building, market assessments, market sizing, and RWE for global MNC healthcare & biopharma clients across diff. markets (America, Europe, Africa, APAC and Middle East). Her areas of expertise include: Indentifying emerging trends in life sciences industry, Competitor landscape assessment, Disease opportunity assessments etc. She is a pro in secondary and primary research with a deep domain expertise in healthcare sector.

More Related